Logo image of COV.CA

COVALON TECHNOLOGIES LTD (COV.CA) Stock Overview

TSX-V:COV - CA22282D3022 - Common Stock

2.4 CAD
+0.03 (+1.27%)
Last: 8/28/2025, 7:00:00 PM

COV.CA Key Statistics, Chart & Performance

Key Statistics
52 Week High4.3
52 Week Low2.06
Market Cap65.81M
Shares27.42M
Float11.71M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)0.13
PE18.46
Fwd PE21.18
Earnings (Next)01-05 2026-01-05
IPO09-03 2004-09-03
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


COV.CA short term performance overview.The bars show the price performance of COV.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -2 -4 -6

COV.CA long term performance overview.The bars show the price performance of COV.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20

The current stock price of COV.CA is 2.4 CAD. In the past month the price decreased by -5.88%. In the past year, price decreased by -23.32%.

COVALON TECHNOLOGIES LTD / COV Daily stock chart

COV.CA Competitors/Peers

The largest stocks on the Canadian markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
EDT.CA SPECTRAL MEDICAL INC N/A 423.01M
FRX.CA FENNEC PHARMACEUTICALS INC N/A 347.88M
EPRX.CA EUPRAXIA PHARMACEUTICALS INC N/A 256.75M
TH.CA THERATECHNOLOGIES INC N/A 205.53M
BCT.CA BRIACELL THERAPEUTICS CORP N/A 190.28M
ONC.CA ONCOLYTICS BIOTECH INC N/A 126.12M
HBP.CA HELIX BIOPHARMA CORP N/A 96.41M
WLLW.CA WILLOW BIOSCIENCES INC N/A 88.12M
MDNA.CA MEDICENNA THERAPEUTICS CORP N/A 87.58M
BLU.CA BLUENERGIES LTD N/A 69.74M
MSCL.CA SATELLOS BIOSCIENCE INC N/A 60.21M
SVA.CA SERNOVA BIOTHERAPEUTICS INC N/A 48.52M

About COV.CA

Company Profile

COV logo image Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of patent-protected medical products. The company is headquartered in Mississauga, Ontario. The company went IPO on 2004-09-03. The firm's solutions are designed for patients and made for care providers. The firm leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon's name, and by developing and commercializing medical products for other medical companies under development and license contracts. The firm has three proprietary platform technologies that have the potential to be developed into a number of medical devices and products: Collagen matrix, Antimicrobial silicone adhesive and Medical coatings. Its product type includes advanced wound care, antimicrobial dressings, collagen dressings, IV dressings, and perioperative dressings. Its brands include ColActive PLUS, CovaClear, CovaView, CovaWound, IV Clear, SurgiClear, and VALGuard.

Company Info

COVALON TECHNOLOGIES LTD

1660 Tech Avenue, Unit 5

Mississauga ONTARIO L4W 5S7 CA

CEO: Simon Smith

Employees: 41

COV Company Website

COV Investor Relations

Phone: 18777116055

COVALON TECHNOLOGIES LTD / COV.CA FAQ

What is the stock price of COVALON TECHNOLOGIES LTD today?

The current stock price of COV.CA is 2.4 CAD. The price increased by 1.27% in the last trading session.


What is the ticker symbol for COVALON TECHNOLOGIES LTD stock?

The exchange symbol of COVALON TECHNOLOGIES LTD is COV and it is listed on the TSX Venture Exchange exchange.


On which exchange is COV.CA stock listed?

COV.CA stock is listed on the TSX Venture Exchange exchange.


What is the price forecast or stock price prediction for COVALON TECHNOLOGIES LTD stock?

9 analysts have analysed COV.CA and the average price target is 3.83 CAD. This implies a price increase of 59.38% is expected in the next year compared to the current price of 2.4. Check the COVALON TECHNOLOGIES LTD stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is COVALON TECHNOLOGIES LTD worth?

COVALON TECHNOLOGIES LTD (COV.CA) has a market capitalization of 65.81M CAD. This makes COV.CA a Micro Cap stock.


How many employees does COVALON TECHNOLOGIES LTD have?

COVALON TECHNOLOGIES LTD (COV.CA) currently has 41 employees.


What are the support and resistance levels for COVALON TECHNOLOGIES LTD (COV.CA) stock?

COVALON TECHNOLOGIES LTD (COV.CA) has a support level at 2.35 and a resistance level at 2.49. Check the full technical report for a detailed analysis of COV.CA support and resistance levels.


Is COVALON TECHNOLOGIES LTD (COV.CA) expected to grow?

The Revenue of COVALON TECHNOLOGIES LTD (COV.CA) is expected to grow by 10.76% in the next year. Check the estimates tab for more information on the COV.CA EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy COVALON TECHNOLOGIES LTD (COV.CA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does COVALON TECHNOLOGIES LTD (COV.CA) stock pay dividends?

COV.CA does not pay a dividend.


When does COVALON TECHNOLOGIES LTD (COV.CA) report earnings?

COVALON TECHNOLOGIES LTD (COV.CA) will report earnings on 2026-01-05.


What is the Price/Earnings (PE) ratio of COVALON TECHNOLOGIES LTD (COV.CA)?

The PE ratio for COVALON TECHNOLOGIES LTD (COV.CA) is 18.46. This is based on the reported non-GAAP earnings per share of 0.13 and the current share price of 2.4 CAD. Check the full fundamental report for a full analysis of the valuation metrics for COV.CA.


COV.CA Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to COV.CA. When comparing the yearly performance of all stocks, COV.CA is a bad performer in the overall market: 86.97% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

COV.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to COV.CA. COV.CA scores excellent points on both the profitability and health parts. This is a solid base for a good stock.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

COV.CA Financial Highlights

Over the last trailing twelve months COV.CA reported a non-GAAP Earnings per Share(EPS) of 0.13. The EPS increased by 225.38% compared to the year before.


Industry RankSector Rank
PM (TTM) 10.92%
ROA 10.52%
ROE 11.87%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-63.41%
Sales Q2Q%-10.75%
EPS 1Y (TTM)225.38%
Revenue 1Y (TTM)28.97%

COV.CA Forecast & Estimates

9 analysts have analysed COV.CA and the average price target is 3.83 CAD. This implies a price increase of 59.38% is expected in the next year compared to the current price of 2.4.

For the next year, analysts expect an EPS growth of -61.54% and a revenue growth 10.76% for COV.CA


Analysts
Analysts84.44
Price Target3.83 (59.58%)
EPS Next Y-61.54%
Revenue Next Year10.76%

COV.CA Ownership

Ownership
Inst OwnersN/A
Ins Owners5.11%
Short Float %N/A
Short RatioN/A